Request a document copy: Risk of Stroke/Systemic Embolism, Major Bleeding and Associated Costs in Non-Valvular Atrial Fibrillation Patients Who Initiated Apixaban, Dabigatran or Rivaroxaban Compared With Warfarin in the United States Medicare Population

Requester name:

Requester e-mail:

Files:

all files (of this document) in restricted access

the file(s) you requested

Message:

Cancel Send